Axsome Therapeutics Inc.
AXSM | NASDAQ
$144.43
+$0.98 (+0.68%)
At close: Oct 30, 2026, 4:00 PM ET
$139.85
-$4.58 (-3.17%)
Pre-market:
Nov 2, 2026, 9:26 AM ET
Market Data
Market Cap $7.57B
Enterprise Value $7.46B
Beta 0.60
Average Volume 862.16K
Shares Outstanding (Diluted) 51.5M
Shares Change YoY 4.16%
Institutional Ownership 75.30%
Exchange NASDAQ
ISIN US05464T1043
Price Performance
Price Change 1M -21.7%
Price Change 3M -33.7%
Price Change 6M -30.1%
Price Change YTD -20.9%
Price Change 1Y 7.0%
Price Change 3Y 131.9%
Price Change 5Y 275.1%
1M CAGR (ann.) -30.5%
1Y CAGR (ann.) 8.3%
5Y CAGR (ann.) 29.2%
All-Time CAGR 36.6%
Valuation
PE Ratio -38.51
Forward PE 33.96
PEG Ratio -1.36
Forward PEG 1.77
PS Ratio 9.74
Forward PS 5.00
PB Ratio 90.82
P/FCF Ratio -105.98
P/Adj. FCF Ratio -45.08
P/OCF Ratio -104.66
EV/Sales 9.61
EV/EBIT -40.12
EV/EBITDA -41.52
EV/FCF -104.57
Earnings Yield -2.6%
FCF Yield -0.9%
Adj. FCF Yield -2.2%
Financial Health
Net Cash $131.89M
Total Debt $219.21M
Cash & Short-Term Investments $319.85M
Total Assets $761.45M
Current Ratio 1.43
Quick Ratio 1.34
Debt / Equity Ratio 2.63
Debt / EBITDA -1.22
Debt / FCF -3.07
OCF / Debt -0.33
Interest Coverage -37.58
Altman Z-Score 4.60
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 93.2%
Operating Profit Margin -24.3%
EBITDA Margin -22.7%
Net Profit Margin -24.7%
FCF Margin -9.2%
Adj. FCF Margin -21.6%
SBC / Revenue 12.4%
SBC Impact (per share) -135.1%
Returns
Return on Assets -25.2%
Return on Equity -255.6%
Return on Invested Capital -50.7%
Return on Capital Employed -62.6%
Return on Tangible Assets -26.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 62.0%
Revenue CAGR 5Y 52.7%
Revenue CAGR 10Y 43.1%
EPS CAGR 3Y 27.0%
EPS CAGR 5Y -1.0%
EPS CAGR 10Y -14.6%
FCF CAGR 3Y 40.2%
FCF CAGR 5Y 7.8%
FCF CAGR 10Y -13.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 15
EPS Growth Next 3Y 222.4%
Revenue Growth Next 3Y 56.0%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.63
EPS Growth Est (next Q) -32.5%
Revenue Est (next Q) $249.19M
Revenue Growth Est (next Q) 45.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $281.67
Price Target Upside 95.0%
Cash Flow
Operating Cash Flow $-71.26M
Free Cash Flow $-71.39M
Adj. Free Cash Flow $-167.81M
FCF Per Share -$1.39
OCF Per Share -$1.38
OCF/S Ratio -9.2%
Income Statement
Revenue $776.57M
Gross Profit $724.04M
Operating Income $-188.54M
EBITDA $-179.79M
Net Income $-191.64M
EPS (Diluted) -$3.75
Revenue / Employee $576.95K
Profit / Employee $-142.38K
Employees 1,346
Add to Watchlist
Select watchlists to add or remove AXSM